One World Pharma Adds Robinson Ortega Tafur as Production & Operations Supervisor
Veteran Colombian Agro Specialist to Oversee Farm Operations as Company Enters Revenue Phase
LAS VEGAS, NV, Sept. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that the Company has retained Robinson Ortega Tafur as its new Production & Operations Supervisor for its farms in Colombia.
Tafur brings to OWP a wealth of experience growing in Colombia. He is an Agronomy Engineer and Rural Agro-Industry Development Specialist with broad professional experience in support, coordination, monitoring and supervision processes and has overseen production of a wide variety of crops grown in Colombia and with the indigenous peoples.
“Mr. Tafur is a welcome addition to the One World Pharma team and I believe he has the ideal skill set to oversee our new successes in Colombia,” stated Isiah Thomas, CEO, One World Pharma. “We are now entering an exciting phase for the Company as our labors to date have earned us the right to at last begin to produce cannabis ingredients at scale and to commercialize our harvests.”
“I’m honored to become a member of this tremendous management team and to join our employees and partners in producing and preparing for sale the finest cannabis ingredients in the world,” stated Tafur. “One World Pharma has established a tremendous growing operation and collaborative relationship with the indigenous people and our government. Now, it is time to harvest and I firmly believe my experience overseeing and completing a variety of different harvests in Colombia has prepared me well for this opportunity.”
About One World Pharma
Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.
One World Pharma Investor Relations & Financial Media
Kurt Divich, CEO
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Released September 8, 2020
